rs876661121
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_000214.3(JAG1):c.3048+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000214.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JAG1 | ENST00000254958.10 | c.3048+1G>T | splice_donor_variant, intron_variant | Intron 24 of 25 | 1 | NM_000214.3 | ENSP00000254958.4 | |||
JAG1 | ENST00000617357.1 | n.165G>T | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 | |||||
JAG1 | ENST00000423891.6 | n.2914+1G>T | splice_donor_variant, intron_variant | Intron 22 of 24 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
The c.3048+1 G>T splice site variant in the JAG1 gene has been previously reported in association with Alagille syndrome (Warthen et al., 2006). This pathogenic variant destroys the canonical splice donor site in intron 24, and causes abnormal gene splicing (Boyer et al., 2005). Additionally, the variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, the presence of this pathogenic variant is consistent with a diagnosis of Alagille syndrome. -
- -
Alagille syndrome due to a JAG1 point mutation Pathogenic:1Uncertain:1
This sequence change affects a donor splice site in intron 24 of the JAG1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with Alagille syndrome (PMID: 15772854). ClinVar contains an entry for this variant (Variation ID: 234615). Studies have shown that disruption of this splice site results in skipping of exon 24, but is expected to preserve the integrity of the reading-frame (PMID: 15772854). This variant disrupts a region of the JAG1 protein in which other variant(s) (p.Cys1002Arg) have been observed in individuals with JAG1-related conditions (PMID: 31343788). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The splice donor c.3048+1G>T variant in the JAG2 gene has been previously reported in association with Alagille syndrome (Gilbert, Melissa A et al., 2019). The variant is absent in gnomAD Exomes and 1000 Genomes. It is submitted to ClinVar database as Pathogenic. The variant affects the GT donor splice site downstream of exon 24. It is present in the penultimate intron and so functional studies are required to prove the pathogenicity of the variant. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at